Looking back to 176 days ago, Valeant Pharmaceuticals International (NYSE: VRX) priced a 23,529,412 share secondary stock offering at $85.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday, the stock is now 26.1% above the offering price.
Looking back to 176 days ago, Valeant Pharmaceuticals International (NYSE: VRX) priced a 23,529,412 share secondary stock offering at $85.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday, the stock is now 26.1% above the offering price.
Share this Article
Comment on this Article
Recommended
Please to comment